Skip to main content

COVID-19 Advisory: Visitor restrictions are in place for all Phoenix Children’s locations. Masks are required for all visitors and for patients ages 2+. For more information, visit our COVID-19 Resource Center.

Jessica L. Boklan, MD

Edit Profile

Director, Clinical Oncology Research; Director, Early Drug Development Program; Co-Director, Leukemia, Lymphoma, Histiocytosis Program



Areas of Expertise

  • Pediatrics Pediatric Oncology Pediatric Hematology Leukemia Cancer Drug Dev. Bone Marrow Failure


Phoenix Children's Hospital - Main
1919 E. Thomas Rd., Phoenix, Arizona 85016

About Jessica L. Boklan, MD

Dr. Boklan has been a faculty member at Phoenix Children's Hospital since 2001. Her clinical focus is on leukemia, with an emphasis on the various types of myeloid leukemias. She is Co-Director of the hospital's Leukemia Program. Dr. Boklan also specializes in care for children with bone marrow failure syndromes including aplastic anemia. In addition to her areas of clinical focus, Dr. Boklan is Director of Clinical Oncology Research where she supervises all oncology clinical trials carried out at PCH. Her specific interest is in early drug development. As Director of the Early Drug Development Program, she concentrates on evaluating new drugs for patients who do not respond to currently available pediatric cancer treatments.

Dr. Boklan grew up in New York. She obtained her BA in Biochemical Sciences with honors from Harvard University. As an undergraduate, she spent two years in a laboratory, studying the molecular underpinnings of cancer development. She was awarded the Eliot House thesis prize for her work. Dr. Boklan received her MD from New York University School of Medicine where she was elected to the Alpha Omega Alpha Honor Society as well as earning numerous other academic achievement awards. Dr. Boklan then completed her residency in pediatrics at Children's Hospital of Philadelphia followed by her pediatric hematology-oncology fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) and New York Hospital. Dr. Boklan's fellowship research involved stem cell gene therapy and looking at new approaches for molecularly-targeted cancer treatment. Following completion of her fellowship, Dr. Boklan spent an additional year continuing her research at MSKCC as the Charles H. Revson Fellow in Biomedical Research and Charles A. Dana Postdoctoral Research Fellow.

Dr. Boklan subsequently moved across the country to Phoenix, where she joined the faculty of Phoenix Children's Hospital. Since her arrival, she has built the oncology clinical research program into one with international recognition and membership in multiple prestigious consortia alongside some of the world's major pediatric cancer centers. She currently serves as the PCH Principal Investigator for the Children's Oncology Group (COG), the Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC) and Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL). Dr. Boklan works with her clinical partners in other academic centers as well as pharmaceutical companies to develop studies with the most promising agents available and bring them to pediatric patients. She also works closely with her laboratory collaborators to investigate new targeted agents and determine which would be best to move forward into clinical trials.

When Dr. Boklan is not running around caring for patients or supervising trials, she can be found in the hallways playing with her furry associates. Dr. Boklan also serves as the Medical Advisor for the PCH's Animal Assisted Therapy Program.
Share this page


Education & Training

Board Certification

Pediatric Hematology/Oncology; General Pediatrics

Medical School / Education

New York University School of Medicine, New York, NY


Children's Hospital of Philadelphia, Philadelphia, PA


(Pediatric Hematology/Oncology) Memorial Sloan-Kettering Cancer Center, New York, NY

Academic Affiliations

Assistant Professor of Clinical Pediatrics, University of Arizona College of Medicine, Tucson, AZ; Associate Member, Arizona Cancer Center

Professional Affiliations

American Academy of Pediatrics; American Association for Cancer Research; American Society of Hematology; Arizona Children's Therapeutic and Investigational Oncology Network; Pediatric Oncology Experimental Therapeutics Investigators' Consortium; Pediatric Blood and Cancer; Children's Oncology Group; American Society of Clinical Oncology; Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL)


  • Best-Doc
  • Women's Medical Association Citation for outstanding academic achievement (1994); Rosa Lee Nemir Award for outstanding performance in pediatrics (1994); Health Care Hero - Researcher/Scientist (Arizona Business Journal) (2007); Linda Rainford Award for outstanding work in the field of cancer education, prevention, and treatment (Desert Cancer Foundation of Arizona) (2007); 1st Annual Health Care Leadership Award - Research (Arizona Business Magazine) (2008); Forty-Under-40 for up and coming community leaders (Phoenix Business Journal) (2008)

Research & Publications

Boklan J. Little Patients, Losing Patience: Pediatric Cancer Drug Development. Commentary. Molecular Cancer Therapeutics. August 2006, Vol 5(8); 1905-1908.

Gao S, Mobley A, Miller C, Boklan J, Chandra J. Potentiation of reactive oxygen speci
Leukemia, Bone Marrow Failure, New Cancer Drug Development<br/>